查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1629899

全球生物基包装市场 - 2025-2033

Global Bio Based Packaging Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 159 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球生物基包装市场将于 2024 年达到 19 亿美元，预计到 2033 年将达到 40 亿美元，在 2025-2033 年预测期间复合年增长率为 8.5%。

医疗保健生物基包装是指专门为製药、医疗器材和医疗保健行业设计的包装解决方案，由可再生的生物来源材料製成，而不是传统的塑胶或其他不可生物降解的材料。这些包装解决方案的开发是为了满足医疗保健行业的严格要求，例如无菌、屏障保护、耐用性和安全性，同时又环保。

随着医疗保健公司和消费者认识到永续发展和减少包装材料对环境影响的重要性，医疗保健产业对生物基包装的需求一直在稳步增长。例如，根据英国製药工业协会 (ABPI) 的数据，大约 70% 至 80% 的碳足迹来自製造过程，这些製造过程的设计者和发明者表示，所做的决定将与该产品一起持续存在。作为药物的剩余使用寿命。

市场动态：

驱动程式和限制

製药公司不断提高的永续发展目标

製药公司不断提高的永续发展目标正在显着推动生物基包装市场的成长，预计将在预测期内推动市场发展。主要製药公司正在製定雄心勃勃的永续发展目标，例如透过使用生物基包装材料将永续发展纳入其企业策略来实现净零排放或减少碳足迹来实现这些目标。

例如，2024 年 10 月，TekniPlex Healthcare 推出了首款经 ISCC PLUS 认证的生物基 PVC 化合物，为医疗包装提供了可持续的替代品。其新材料设计用于医疗包装应用，如管材、托盘薄膜、袋子和其他塑胶零件，提供环保选择。其化合物采用再生能源製成，可减少高达 90% 的二氧化碳排放，帮助医疗保健产业在不损失性能或安全性的情况下创造更永续的包装。

FDA 和 EMA 等监管机构越来越重视减少医疗保健产业包装材料对环境的影响。这些法规鼓励采用永续实践，包括透过 ISO 合规性等认证来使用生物基包装材料。

例如，2024 年1 月，专业和永续材料解决方案和服务的领先供应商Avient Corporation 宣布将在Pharmapack 2024 上重点展示其生物基聚合物解决方案组合。添加剂以及生物基聚合物解决方案。

严格的监管要求

严格的监管要求造成了合规性复杂化、成本增加和市场采用受限等障碍，严重阻碍了生物基包装市场的成长。由于药品包装的重要性，这些法规在医疗保健领域尤其严格。生物基包装必须符合与传统材料在製药应用中的安全性、无菌性和功能性相同的严格标准。这包括严格的生物相容性测试、稳定性测试以及与包装内药物或医疗器材的兼容性。

例如，FDA 要求生物基包装材料经过广泛的测试，以证明它们不会与药品或医疗设备等内容物产生负面交互作用。例如，材料不得浸出有害物质或损害药物或设备的完整性。与传统塑胶相比，这些要求使得生物基材料的监管过程更加复杂和耗时。

不同地区对生物基材料的监管要求差异很大，这给希望在全球销售产品的公司带来了挑战。例如，与欧盟的 REACH（化学品註册、评估、授权和限制）法规相比，美国 FDA 的法规有所不同。这些差异使生物基包装製造商标准化其产品以适应国际市场的能力变得更加复杂。

目录

第一章：市场介绍和范围

  • 报告的目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按材料类型分類的片段
  • 按应用程式片段
  • 按地区分類的片段

第 3 章：动力学

  • 影响因素
    • 司机
      • 製药公司不断提高的永续发展目标
    • 限制
      • 严格的监管要求
    • 机会
    • 影响分析

第 4 章：策略洞察与产业展望

  • 市场领导者和先驱
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的知名领导者
    • 拥有成熟产品的市场领导者
  • 新兴新创企业和关键创新者
  • CXO 观点
  • 最新进展和突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态

第 5 章：生物基包装市场（依材料类型）

  • 生物降解塑料
  • 可生物降解的纸和纸板
  • 可生物降解薄膜
  • 其他的

第 6 章：生物基包装市场（依应用）

  • 製药及生物製药业
  • 营养保健品公司
  • 个人护理和化妆品
  • 其他的

第 7 章：生物基包装市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 8 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的主要发展
  • 公司基准化分析

第 9 章：公司简介

  • Amcor plc
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
    • SWOT分析
  • Gerresheimer AG
  • SCHOTT Pharma
  • Becton, Dickinson, and Company
  • DS Smith
  • Berry Global Inc.
  • Smurfit Kappa
  • Sanner GmbH
  • Avient Corporation
  • Bormioli Pharma SpA

第 10 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 11 章：附录

简介目录
Product Code: OT8933

The global bio based packaging market reached US$ 1.9 billion in 2024 and is expected to reach US$ 4.0 billion by 2033, growing at a CAGR of 8.5% during the forecast period 2025-2033.

Healthcare bio-based packaging refers to packaging solutions specifically designed for the pharmaceutical, medical device, and healthcare industries that are made from renewable, biologically sourced materials rather than conventional plastics or other non-biodegradable materials. These packaging solutions are developed to meet the stringent requirements of the healthcare sector, such as sterility, barrier protection, durability, and safety, while also being environmentally friendly.

The demand for bio-based packaging in the healthcare sector has been growing steadily as healthcare companies and consumers alike recognize the importance of sustainability and reducing the environmental impact of packaging materials. For instance, according to the Association of the British Pharmaceutical Industry (ABPI), about 70 to 80% of the carbon footprint sits in the manufacturing process and as the designers and inventors of those manufacturing processes say the decisions made will live with that product for the rest of its useful life as a medicine.

Market Dynamics: Drivers & Restraints

Rising sustainability goals of pharmaceutical companies

The rising sustainability goals of pharmaceutical companies are significantly driving the growth of the bio based packaging market and are expected to drive the market over the forecast period. Major pharmaceutical companies are setting ambitious sustainability targets, such as achieving net-zero emissions or reducing their carbon footprint by integrating sustainability into their corporate strategies by using bio-based packaging materials to meet these goals.

For instance, in October 2024, TekniPlex Healthcare unveiled the first ISCC PLUS-certified bio-based PVC compounds, offering a sustainable alternative for medical packaging. Its new materials are designed for use in medical packaging applications like tubing, films for trays, pouches, and other plastic components, providing eco-friendly options. Made with renewable energy, its compounds reduce CO2 emissions by up to 90%, helping the healthcare industry create more sustainable packaging without losing performance or safety.

Regulatory bodies, such as the FDA and EMA, are increasingly focused on reducing the environmental impact of packaging materials in the healthcare sector. These regulations encourage the adoption of sustainable practices, including the use of bio-based packaging materials by obtaining certifications like ISO compliance.

For instance, in January 2024, Avient Corporation, a leading provider of specialized and sustainable material solutions and services, announced it is highlighting its portfolio of bio-based polymer solutions at Pharmapack 2024. These solutions include bio-based polymer colorants and additives and bio-derived thermoplastic elastomers with lower product carbon footprint (PCF) values substantiated by Avient's PCF Calculator certified by TUV Rheinland for ISO 14067 compliance.

Stringent regulatory requirements

Stringent regulatory requirements significantly hamper the growth of the bio-based packaging market by creating barriers that complicate compliance, increase costs and limit market adoption. These regulations are particularly stringent in the healthcare sector due to the critical nature of pharmaceutical packaging. Bio-based packaging must meet the same rigorous standards as traditional materials for safety, sterility, and functionality in pharmaceutical applications. This includes rigorous biocompatibility tests, stability tests, and compatibility with the drug or medical device within the packaging.

For instance, the FDA requires bio-based packaging materials to undergo extensive testing to demonstrate that they do not interact negatively with the contents, such as pharmaceuticals or medical devices. Like, materials must not leach harmful substances or compromise the integrity of the drug or device. These requirements make the regulatory process more complex and time-consuming for bio-based materials compared to traditional plastics.

The regulatory requirements for bio-based materials vary significantly across different regions, creating challenges for companies looking to market their products globally. For instance, the FDA in the U.S. has different regulations compared to the EU's REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) regulations. These differences complicate the ability of bio-based packaging manufacturers to standardize their products for international markets.

Segment Analysis

The global bio based packaging market is segmented based on material type, application and region.

Material Type:

The biodegradable plastics segment is expected to dominate the bio based packaging market share

Biodegradable plastics are derived from renewable resources like corn starch, sugarcane, or polylactic acid (PLA). These materials can break down more easily in natural environments, reducing the overall environmental footprint compared to conventional plastics, which can persist for hundreds of years in landfills. Biodegradable plastics can be engineered to have similar properties to traditional plastics, such as durability, moisture resistance, and chemical resistance, making them suitable for packaging pharmaceuticals and medical devices.

For instance, in October 2024, Bayer launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve. Realized in partnership with pharma packaging specialist Liveo Research, this innovative solution reduces the carbon footprint of this packaging by 38% and marks a stride in environmental stewardship by eliminating the use of polyvinyl chloride (PVC).

Rising investments in biodegradable plastics are also increasing the market demand. For instance, in September 2024, Darmstadt-based BIOVOX announced the successful closing of its €2.2 million seed round. The round was led by High-Tech Grunderfonds (HTGF) with significant participation from Beteiligungs-Managementgesellschaft Hessen mbH (BMH) and a group of existing and new investors including Auxxo, Otto Braun, Petra Worwag and Katharina Klohe as well members of the business angel club better ventures and Business Angels FrankfurtRheinMain. The investment will enable BIOVOX to accelerate the development and production of its portfolio of innovative bioplastic solutions designed to revolutionize the healthcare industry.

Geographical Analysis

North America is expected to hold a significant position in the bio based packaging market share

North America, particularly the United States and Canada, has a strong regulatory framework that encourages the adoption of sustainable packaging materials in the healthcare sector. The US FDA and Canadian regulatory bodies are pushing for more sustainable solutions to reduce the environmental impact of pharmaceutical packaging.

For instance, the FDA has issued guidance on the use of environmentally friendly packaging materials, including bio-based plastics, to ensure the safety and efficacy of pharmaceuticals. The directive is aimed at promoting packaging that is not only effective in protecting products but also sustainable.

In North America, there is a growing consumer preference for environmentally friendly products, which influences pharmaceutical companies to seek sustainable packaging solutions. Consumers are becoming more aware of the environmental impact of packaging materials and are demanding more eco-friendly options. This trend is particularly strong among younger demographics, who are more likely to choose sustainable products. For instance, according to the survey conducted by Accenture found that 83% of US consumers believe it's important for companies to design products that are environmentally friendly.

Asia-Pacific is growing at the fastest pace in the bio based packaging market

The Asia-Pacific region is witnessing significant economic growth, especially in countries like China, India, and Japan. This economic development is leading to an increased demand for healthcare products, which in turn drives the need for sustainable packaging solutions. As disposable incomes rise and urbanization accelerates, consumers are becoming more aware of the environmental impact of packaging and are increasingly demanding eco-friendly alternatives.

For instance, in China, the healthcare packaging market is expanding rapidly due to an aging population and increased healthcare spending. This growth is prompting the adoption of bio-based packaging to meet the demands of the pharmaceutical industry, which is under pressure to reduce waste and comply with stricter environmental regulations.

Major pharmaceutical companies in the APAC region are setting ambitious sustainability targets and are actively seeking bio-based packaging solutions to meet these goals. For example, companies like Cipla, Sun Pharmaceutical Industries, and Aurobindo Pharma in India are increasingly using bio-based packaging materials to meet global standards and enhance their sustainability profiles.

Competitive Landscape

The major global players in the bio based packaging market include Amcor plc, Gerresheimer AG, SCHOTT Pharma, Becton, Dickinson, and Company, DS Smith, Berry Global Inc., Smurfit Kappa, Sanner GmbH, Avient Corporation, Bormioli Pharma S.p.A. and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global bio based packaging market report delivers a detailed analysis with 54 key tables, more than 44 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Material Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising sustainability goals of pharmaceutical companies
    • 3.1.2. Restraints
      • 3.1.2.1. Stringent regulatory requirements
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Bio Based Packaging Market, By Material Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 5.1.2. Market Attractiveness Index, By Material Type
  • 5.2. Biodegradable Plastics*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Biodegradable Paper and Paperboard
  • 5.4. Biodegradable Films
  • 5.5. Others

6. Bio Based Packaging Market, By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Pharmaceutical & Biopharmaceutical Industries*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Nutraceutical Companies
  • 6.4. Personal Care and Cosmetics
  • 6.5. Others

7. Bio Based Packaging Market, By Regional Market Analysis and Growth Opportunities

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 7.1.2. Market Attractiveness Index, By Region
  • 7.2. North America
    • 7.2.1. Introduction
    • 7.2.2. Key Region-Specific Dynamics
    • 7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.2.5.1. U.S.
      • 7.2.5.2. Canada
      • 7.2.5.3. Mexico
  • 7.3. Europe
    • 7.3.1. Introduction
    • 7.3.2. Key Region-Specific Dynamics
    • 7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.3.5.1. Germany
      • 7.3.5.2. U.K.
      • 7.3.5.3. France
      • 7.3.5.4. Spain
      • 7.3.5.5. Italy
      • 7.3.5.6. Rest of Europe
  • 7.4. South America
    • 7.4.1. Introduction
    • 7.4.2. Key Region-Specific Dynamics
    • 7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.4.5.1. Brazil
      • 7.4.5.2. Argentina
      • 7.4.5.3. Rest of South America
  • 7.5. Asia-Pacific
    • 7.5.1. Introduction
    • 7.5.2. Key Region-Specific Dynamics
    • 7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.5.5.1. China
      • 7.5.5.2. India
      • 7.5.5.3. Japan
      • 7.5.5.4. South Korea
      • 7.5.5.5. Rest of Asia-Pacific
  • 7.6. Middle East and Africa
    • 7.6.1. Introduction
    • 7.6.2. Key Region-Specific Dynamics
    • 7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

8. Competitive Landscape and Market Positioning

  • 8.1. Competitive Overview and Key Market Players
  • 8.2. Market Share Analysis and Positioning Matrix
  • 8.3. Strategic Partnerships, Mergers & Acquisitions
  • 8.4. Key Developments in Product Portfolios and Innovations
  • 8.5. Company Benchmarking

9. Company Profiles

  • 9.1. Amcor plc*
    • 9.1.1. Company Overview
    • 9.1.2. Product Portfolio and Description
    • 9.1.3. Financial Overview
    • 9.1.4. Key Developments
    • 9.1.5. SWOT Analysis
  • 9.2. Gerresheimer AG
  • 9.3. SCHOTT Pharma
  • 9.4. Becton, Dickinson, and Company
  • 9.5. DS Smith
  • 9.6. Berry Global Inc.
  • 9.7. Smurfit Kappa
  • 9.8. Sanner GmbH
  • 9.9. Avient Corporation
  • 9.10. Bormioli Pharma S.p.A.

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

  • 10.1. Data Collection Methods
  • 10.2. Data Triangulation
  • 10.3. Forecasting Techniques
  • 10.4. Data Verification and Validation

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us